Bill · H.R. 9676· House(119-HR-9676)
Examining Opioid Treatment Infrastructure Act of 2026
- Introduced
- 7/14/2026
- Last activity
- 7/14/2026 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsored by
- Bill Foster
- Cosponsors
- None
- Introduced
- In Committee
What this bill would do
The Examining Opioid Treatment Infrastructure Act of 2026 requires the Comptroller General of the United States to conduct an evaluation of opioid-use disorder treatment. Within 24 months of the law passing, a report must be submitted to Congress. This report will cover the capacity, availability, and needs for both inpatient and outpatient treatment across the country. It includes looking at specific programs, geographical differences, and barriers to reporting overdose data.
Yes· 3 of 27
Does this do more about addiction and overdose deaths?+7
The bill mandates a comprehensive evaluation of opioid treatment capacity and overdose reporting to better address the crisis.
Would Native Americans be better off under this?+6
The bill specifically requires an evaluation of treatment availability for American Indians and Alaska Natives.
Would women be better off under this?+5
The bill specifically assesses treatment programs designed for pregnant women.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Assessment of Treatment Needs: Section 2(7) directs an assessment of the need for residential and outpatient treatment, which helps identify where more help is required.
-
Focus on Specialized Care: Section 2(3) looks at the capacity of programs designed for specific groups, such as adolescents or pregnant women.
-
Evidence-Based Options: Section 2(5) evaluates the availability of programs using reliable scientific evidence, including FDA-approved medicines and nonpharmacological therapies.
-
Tribal Health Support: Section 2(8) examines the availability of treatment for American Indians and Alaska Natives through Indian health programs.
-
Improving Data: Section 2(9) seeks to identify and overcome barriers to real-time reporting of de-identified drug overdose information.
Potential Negative Impacts for People
- No negative impacts for individuals or groups are explicitly mentioned in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Native Americans+6Good For Women+5Good For Low Income Households+4Good For Rural Residents+4Good For African Americans+3Good For Asian Americans+3Good For Children+3Good For Hispanic Americans+3Good For Men+3Good For Middle Aged+3Good For Middle Class Households+3Good For Retirees+3Good For Seniors+3Good For Students+3Good For Urban Residents+3Good For Veterans+3Good For White Americans+3Good For Young Adults+3Good For High Income Households+2
- Healthcare
- Improves Opioid Crisis Response+7Improves Healthcare Access+4Improves Mental Health Access+3
- Governance And Ideology
- Improves Government Transparency+3Increases Federal Power+1
- Social Issues And Justice
- Improves Gender Equality+2Improves Racial Equity+2
- Environment Energy And Infrastructure
- Improves Rural Development+2
- 7/14/2026
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House